Læknablaðið - aug. 2019, Síða 25

LÆKNAblaðið 2019/105 333
1. Luus K. Asbestos: mining exposure, health effects and
policy implications. Mcgill J Med. 2007;10:121–6.
2. Lippmann M. Effects of fiber characteristics on lung
deposition, retention, and disease. Environ Health
Perspect. 1990;88:311–7.
3. Ross M, Nolan R. History of asbestos discovery and use
and asbestos-related disease in context with the occur-
rence of asbestos within ophiolite complexes. Geological
Society of America, Special Paper 373; 2003. p. 447–70.
4. Marco Polo. The Travel of Marco Polo the Venetian.
London: JM Dent, 1908.
5. Cooke WE. Fibrosis of the lungs due to the inhalation of
asbestos dust. Br Med J 1924;2:147.
6. Cooke WE. Pulmonary asbestosis. Br Med J 1927;2:1024-5.
7. McDonald S. Histology of pulmonary asbestosis. Br Med J
1927;2:1025-6.
8. Tweedale G, Hansen P. Protecting the workers: the med-
ical board and the asbestos industry, 1930s-1960s. Med
Hist. 1998;42:439–57.
9. Gloyne SR, Merewether ER. Asbestos. Occupation and
Health: encyclopedia of hygiene, pathology, and social
welfare. Ginevra: International Labour Office 1938;S1-15.
10. Doll R. Mortality from lung cancer in asbestos workers. Br
J Ind Med 1955;12:81-6.
11. Nicholson WJ. The carcinogenicity of chrysotile asbestos –
a review. Ind Health. 2001;39:57–64.
12. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural
mesothelioma and asbestos exposure in the North
Western Cape Province. Br J Ind Med. 1960; 17:260–71.
13. Keal EE. Asbestosis and abdominal neoplasms. Lancet
1960;2:1211-6.
14. International Ban Asbestos Secretariat. Graphics: Charts
and Maps. Available online: http://www.ibasecretariat.
org/graphics_page.php
15. Reid A, Franklin P, Olsen N, Sleith J, Samuel L, Aboagye-
Sarfo P, de Klerk N, Musk AW et al. All-cause mortality
and cancer incidence among adults exposed to blue
asbestos during childhood. Am J Ind Med. 2013;56:133–45.
16. Olsen NJ, Franklin PJ, Reid A, de Klerk NH, Threlfall
TJ, Shilkin K, Musk B. Increasing incidence of malignant
mesothelioma after exposure to asbestos during home
maintenance and renovation. Med J Aust. 2011;195:271–
274.
17. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H.
Asbestos, asbestosis, and cancer, the Helsinki criteria for
diagnosis and attribution 2014: recommendations. Scand J
Work Environ Health 2015;41:5-15.
18. Tomasson K, Gudmundsson G, Briem H, Rafnsson V.
Malignant mesothelioma incidence by nation-wide cancer
registry: a population-based study. J Occup Med Toxicol.
2016;11:37.
19. Selikoff IJ, Churg J, Hammond E. Asbestos exposure and
neoplasia. JAMA. 1964;188:22–6.
20. van Loon AJ, Kant IJ, Swaen GM, Goldbohm RA, Kremer
AM, van den Brandt PA et al. Occupational exposure
to carcinogens and risk of lung cancer: results from The
Netherlands cohort study. Occup Environ Med 1997;
54:817-24.
21. Berman DW, Crump KS. A meta-analysis of asbestos-
related cancer risk that addresses fiber size and mineral
type. Crit Rev Toxicol. 2008;38:49–73.
22. Schwartz DA, Davis CS, Merchant JA, Bunn WB, Galvin
JR, Van Fossen DS, et al. Longitudinal changes in lung
function among asbestos-exposed workers. Am J Respir
Crit Care Med 1994; 150:1243-9.
23. Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H,
Cagle P et al. Pathology of asbestosis- An update of the
diagnostic criteria: Report of the asbestosis committee
of the college of american pathologists and pulmonary
pathology society. Arch Pathol Lab Med 2010; 134:462-80.
24. Elmes PC. The epidemiology and clinical features
of asbestosis and related diseases. Postgrad Med J.
1966;42:623–35.
25. Sette A, Neder JA, Nery LE, Kavakama J, Rodrigues RT,
Terra-Filho M et al. Thin-section CT abnormalities and
pulmonary gas exchange impairment in workers exposed
to asbestos. Radiology 2004; 232:66-74.
26. Arakawa H, Kishimoto T, Ashizawa K, Kato K, Okamoto
K, Honma K et al. Asbestosis and other pulmonary fibrosis
in asbestos-exposed workers: high-resolution CT features
with pathological correlations. Eur Radiol. 2016;26:1485–
92.
27. Aberle DR, Gamsu G, Ray CS. High-resolution CT of
benign asbestos-related diseases: clinical and radiographic
correlation. AJR Am J Roentgenol 1988; 151:883-91.
28. Wilken D, Velasco Garrido M, Manuwald U, Baur X. Lung
function in asbestos-exposed workers, a systematic review
and meta-analysis. J Occup Med Toxicol. 2011 Jul 26;6:21.
29. Robinson BW, Musk AW. Benign asbestos pleural
effusion: diagnosis and course. Thorax 1981; 36:896-900.
30. Copley SJ, Wells AU, Rubens MB, Chabat F, Sheehan RE,
Musk AW, et al. Functional consequences of pleural dise-
ase evaluated with chest radiography and CT. Radiology.
2001;220:237–43.
31. Fujimoto N, Gemba K, Aoe K, Kato K, Yokoyama T, Usami
I et al. Clinical Investigation of Benign Asbestos Pleural
Effusion. Pulm Med 2015; 2015:416179.
32. Hillerdal G. Rounded atelectasis. Clinical experience with
74 patients. Chest 1989; 95:836.
33. Eisenstadt HB. Benign asbestos pleurisy. JAMA.
1965;192:419–21.
34. Paris C, Thierry S, Brochard P, Letourneux M, Schorle E,
Stoufflet A, et al. Pleural plaques and asbestosis: dose- and
time-response relationships based on HRCT data. Eur
Respir J 2009; 34:72-9.
35. Hillerdal G, Lindgren A. Pleural plaques: correlation
of autopsy findings to radiographic findings and
occupational history. Eur J Respir Dis. 1980;61:315–19.
36. Jeebun V, Stenton SC. The presentation and natural
history of asbestos-induced diffuse pleural thickening.
Occup Med (Lond). 2012;62:266–8.
37. Nielsen LS, Baelum J, Rasmussen J, Dahl S, Olsen KE,
Albin M et al. Occupational asbestos exposure and lung
cancer–a systematic review of the literature. Arch Environ
Occup Health. 2014;69:191–206.
38. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure,
cigarette smoking and death rates. Ann N Y Acad Sci 1979;
330:473-90.
39. Kradin RL, Eng G, Christiani DC. Diffuse peritoneal
mesothelioma: A case series of 62 patients including para-
occupational exposures to chrysotile asbestos. Am J Ind
Med 2017; 60:963-7.
40. Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-
occupational exposure to asbestos and risk of pleural
mesothelioma: review and meta-analysis. Occup Environ
Med 2017; 74:838-46.
41. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto
J et al. The expected burden of mesothelioma mortality in
Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–
93.
42. Lacourt A, Lévêque E, Guichard E, Gilg Soit Ilg A,
Sylvestre MP, Leffondré K. et al. Dose-time-response
association between occupational asbestos exposure and
pleural mesothelioma. Occup Environ Med. 2017;74:691–
7.
43. Kindler HL, Ismaila N, Armato SG 3rd, et al. Treatment
of Malignant Pleural Mesothelioma: American Society of
Clinical Oncology Clinical Practice Guideline. J Clin Oncol
2018; 36:1343.
44. Rafnsson V, Jóhannesdóttir SG, Oddsson H, Benediktsson
H, Tulinius H, Magnússon G. Mortality and cancer
incidence among marine engineers and machinists in
Iceland. Scand J Work Environ Health. 1988;:197-200.
45. Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park
EK, Rantanen J. Asbestos: use, bans and disease burden in
Europe. Bull World Health Organ. 2014;92:790–7.
46. Guðmundsdóttir K, Valsdóttir E, Ragnarsson GB, Ísaksson
HJ, Harðardóttir H, Ragnarsson S, et al. Frumkomin
fleiðruæxli á Íslandi 1985-2016. Læknablaðið E29, fylgirit
93, 2017
Heimildir
Barst til blaðsins 20.febrúar 2019, samþykkt til birtingar 12. júní 2019.